Pediatric Clinical Trials Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Pediatric Clinical Trials Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Pediatric Clinical Trials Market:

https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report

According to The Business Research Company’s Pediatric Clinical Trials Global Market Report 2024, The pediatric clinical trials market size has grown strongly in recent years. It will grow from $16.31 billion in 2023 to $17.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to regulatory incentives, unmet medical needs, advancements in pediatric medicine, global public health initiatives, ethical imperatives, pediatric vaccination programs.

The pediatric clinical trials market size is expected to see strong growth in the next few years. It will grow to $22.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to integration of real-world evidence, pediatric biomarker discovery, expanded access programs, pediatric infectious disease research, pediatric cardiology advancements. Major trends in the forecast period include patient-centric trial design, adoption of adaptive trial designs, digital health technologies, global collaboration and consortia, pediatric oncology advancements.

The rise in pediatric cancer cases is expected to propel the pediatric clinical trials market going forward. Pediatric cancer refers to cancers that develop in children and adolescents under the age of 14. Pediatric cancers are extremely uncommon, and their growth and dissemination patterns may be distinct from those of adult tumors. Pediatric clinical trials continue to play a significant role in the advancement of prognosis and treatment. For instance, in January 2023, according to the American Cancer Society, a US-based voluntary health organization, it is estimated that about 9,910 children in the US under the age of 15 will be diagnosed with cancer and about 1,040 children under the age of 15 are expected to die from cancer in 2023. Therefore, the growing healthcare expenditure is driving the pediatric clinical trials market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp

The pediatric clinical trials market covered in this report is segmented –

1) By Phase: Phase I, Phase II, Phase III, Phase IV

2) By Study Design: Treatment Studies, Observational Studies

3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas

Product innovation are a key trend gaining popularity in the pediatric clinical trial market. Companies operating in the pediatric clinical trials market are adopting new innovative products to sustain their position in the market. For instance, in June 2022, The Leukemia & Lymphoma Society, a US-based voluntary health organization, launched Pediatric Acute Leukemia (PedAL) Master Clinical Trial. It is uniquely designed for pediatric acute leukemia where unique tumor biology of each child’s cancer is identified to help match them with the most promising treatment.

The pediatric clinical trials market report table of contents includes: